By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Astex Pharmaceuticals 

4140 Dublin Boulevard
Suite 220
Dublin  California  94568  U.S.A.
Phone: 925-560-0100 Fax: 925-560-0101

Astex Pharmaceuticals is a leader in innovative drug discovery, development and commercialization, committed to the fight against cancer and other life-threatening diseases.

•Fiscal strength with significant cash, ongoing revenues and potential milestone payments

•Productive partnerships with top-tier pharmaceutical companies

•Rich product portfolio with multiple drugs in clinical development

•Visionary leadership backed by a world-class management team

Oncology Focused. We are a leader in innovative small-molecule therapeutics with particular expertise in fragment-based drug discovery, the most important advance in discovery chemistry in the last 20 years. Our primary areas of focus are oncology and hematology.

Financially Strong. We are a publicly traded pharmaceutical company with strong cash reserves and royalty revenues from the sales of our product DACOGEN®. In addition, our partnerships could deliver significant product milestones and future royalties.

Key Statistics

Ownership: Public

Web Site: Astex Pharma
Employees: 95
Symbol: ASTX


Drug Discovery

Company News
Astex Pharma (ASTX) Celebrates As Cancer Drug Receives Marketing Approval In Europe 8/24/2017 11:02:57 AM
InSysBio LLC Announce Renewal Of Agreement With Astex Pharma (ASTX) 7/25/2017 9:40:35 AM
Cambridge-based Astex Pharma (ASTX) Celebrates As Cancer Drug Receives US Marketing Approval 3/14/2017 6:52:47 AM
Astex Pharma (ASTX) To Showcase Its Next-Generation Hypomethylating Agents Being Developed For Treatment Of AML/MDS At The 2016 Annual Meeting Of American Society of Hematology 11/29/2016 11:00:16 AM
Astex Pharma (ASTX) Joins The Dementia Discovery Fund As A Strategic Investor 11/21/2016 12:40:59 PM
Astex Pharma (ASTX) Achieves Milestone On FDA Filing Of New Drug Application (NDA) For LEE011 (Ribociclib) Plus Letrozole As A First-Line Treatment For HR+/HER2- Advanced Breast Cancer 11/1/2016 12:41:44 PM
Astex Pharma (ASTX) and Genentech (RHHBY) Forge a Clinical Trial Deal for Acute Myeloid Leukemia 4/20/2016 6:55:53 AM
Dementia Consortium Signs New Pharma Partner Astex Pharmaceuticals (ASTX) 10/12/2015 9:37:25 AM
Astex Pharmaceuticals (ASTX) Announces Orphan Drug Designation For Guadecitabine (SGI-110) In The Treatment Of Acute Myeloid Leukemia 10/6/2015 12:15:54 PM
Astex Pharmaceuticals (ASTX) Announces Publication Of Key Clinical Data For Guadecitabine (SGI-110) In The Lancet Oncology 8/19/2015 11:10:24 AM